164 related articles for article (PubMed ID: 35293653)
21. hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.
Sabapathy V; Kumar S
J Cell Mol Med; 2016 Aug; 20(8):1571-88. PubMed ID: 27097531
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cells derived from iPSCs expressing interleukin-24 inhibit the growth of melanoma in the tumor-bearing mouse model.
Wu Z; Liu W; Wang Z; Zeng B; Peng G; Niu H; Chen L; Liu C; Hu Q; Zhang Y; Pan M; Wu L; Liu M; Liu X; Liang D
Cancer Cell Int; 2020; 20():33. PubMed ID: 32015693
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic antibody directed osteogenic differentiation of induced pluripotent stem cell derived MSCs.
Wu Q; Yang B; Cao C; Hu K; Wang P; Man Y
Acta Biomater; 2018 Jul; 74():222-235. PubMed ID: 29778895
[TBL] [Abstract][Full Text] [Related]
24. Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci.
Liu B; Chen F; Wu Y; Wang X; Feng M; Li Z; Zhou M; Wang Y; Wu L; Liu X; Liang D
Oncotarget; 2017 Jun; 8(25):40791-40803. PubMed ID: 28388559
[TBL] [Abstract][Full Text] [Related]
25. Quest for alternate personalized clinical source of MSCs: Advancing towards hiPSCs derived iMSCs.
Sabapathy V; Kumar S
Curr Stem Cell Res Ther; 2016; 11(2):99-113. PubMed ID: 26521972
[TBL] [Abstract][Full Text] [Related]
26. Human induced mesenchymal stem cells display increased sensitivity to matrix stiffness.
Gultian KA; Gandhi R; Sarin K; Sladkova-Faure M; Zimmer M; de Peppo GM; Vega SL
Sci Rep; 2022 May; 12(1):8483. PubMed ID: 35589731
[TBL] [Abstract][Full Text] [Related]
27. HLA-Homozygous iPSC-Derived Mesenchymal Stem Cells Rescue Rotenone-Induced Experimental Leber's Hereditary Optic Neuropathy-like Models In Vitro and In Vivo.
Tsai ET; Peng SY; Wu YR; Lin TC; Chen CY; Liu YH; Tseng YH; Hsiao YJ; Tseng HC; Lai WY; Lin YY; Yang YP; Chiou SH; Chen SP; Chien Y
Cells; 2023 Nov; 12(22):. PubMed ID: 37998352
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal stem cells and their use in therapy: what has been achieved?
Fernández Vallone VB; Romaniuk MA; Choi H; Labovsky V; Otaegui J; Chasseing NA
Differentiation; 2013 Jan; 85(1-2):1-10. PubMed ID: 23314286
[TBL] [Abstract][Full Text] [Related]
30. ＜Editors' Choice＞ Mesenchymal stem/stromal cells generated from induced pluripotent stem cells are highly resistant to senescence.
Aoi T; Tanaka A; Furuhashi K; Ikeya M; Shimizu A; Arioka Y; Kushima I; Ozaki N; Maruyama S
Nagoya J Med Sci; 2023 Nov; 85(4):682-690. PubMed ID: 38155616
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of bone marrow-derived mesenchymal stem cells in Xenopus laevis.
Otsuka-Yamaguchi R; Kitada M; Kuroda Y; Kushida Y; Wakao S; Dezawa M
Stem Cell Res; 2021 May; 53():102341. PubMed ID: 33892293
[TBL] [Abstract][Full Text] [Related]
32. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice.
Hu GW; Li Q; Niu X; Hu B; Liu J; Zhou SM; Guo SC; Lang HL; Zhang CQ; Wang Y; Deng ZF
Stem Cell Res Ther; 2015 Apr; 6(1):10. PubMed ID: 26268554
[TBL] [Abstract][Full Text] [Related]
33. In Vitro Modelling of Osteogenesis Imperfecta with Patient-Derived Induced Mesenchymal Stem Cells.
Claeys L; Zhytnik L; Ventura L; Wisse LE; Eekhoff EMW; Pals G; Bravenboer N; Heine VM; Micha D
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542391
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
[TBL] [Abstract][Full Text] [Related]
35. Differentiation and Molecular Properties of Mesenchymal Stem Cells Derived from Murine Induced Pluripotent Stem Cells Derived on Gelatin or Collagen.
Obara C; Takizawa K; Tomiyama K; Hazawa M; Saotome-Nakamura A; Gotoh T; Yasuda T; Tajima K
Stem Cells Int; 2016; 2016():9013089. PubMed ID: 27642306
[TBL] [Abstract][Full Text] [Related]
36. Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor.
Meng X; Su RJ; Baylink DJ; Neises A; Kiroyan JB; Lee WY; Payne KJ; Gridley DS; Wang J; Lau KH; Li G; Zhang XB
Cell Res; 2013 May; 23(5):658-72. PubMed ID: 23478301
[TBL] [Abstract][Full Text] [Related]
37. Site-Specific Integration of TRAIL in iPSC-Derived Mesenchymal Stem Cells for Targeted Cancer Therapy.
Wang Z; Chen H; Wang P; Zhou M; Li G; Hu Z; Hu Q; Zhao J; Liu X; Wu L; Liang D
Stem Cells Transl Med; 2022 Mar; 11(3):297-309. PubMed ID: 35267023
[TBL] [Abstract][Full Text] [Related]
38. Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity.
Wruck W; Graffmann N; Spitzhorn LS; Adjaye J
Front Cell Dev Biol; 2021; 9():717772. PubMed ID: 34604216
[TBL] [Abstract][Full Text] [Related]
39. Using Pre-Clinical Studies to Explore the Potential Clinical Uses of Exosomes Secreted from Induced Pluripotent Stem Cell-Derived Mesenchymal Stem cells.
Zhou AK; Jou E; Lu V; Zhang J; Chabra S; Abishek J; Wong E; Zeng X; Guo B
Tissue Eng Regen Med; 2023 Oct; 20(6):793-809. PubMed ID: 37651091
[TBL] [Abstract][Full Text] [Related]
40. Expansion of human umbilical cord derived mesenchymal stem cells in regenerative medicine.
Rajput SN; Naeem BK; Ali A; Salim A; Khan I
World J Stem Cells; 2024 Apr; 16(4):410-433. PubMed ID: 38690517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
